major
impedi
econom
barrier
especi
gap
financ
obstruct
optim
deliveri
vaccin
develop
countri
thu
mani
effort
underway
develop
next
gener
vaccin
type
highrisk
hpv
studi
develop
dna
construct
base
gene
potenti
immunogen
highli
conserv
among
highrisk
hpv
type
framework
analysi
includ
bcell
epitop
map
tcell
epitop
map
ie
cell
allergen
assess
tap
transport
proteasom
cleavag
popul
coverag
global
templatebas
dock
data
collect
analysi
design
dna
construct
data
indic
candid
helper
tcell
ctl
sequenc
construct
combin
peptid
singl
univers
vaccin
could
involv
world
popul
rate
respect
vitro
studi
show
high
express
rate
multiepitop
dna
construct
cell
moreov
vivo
studi
indic
combin
dna
construct
without
adjuv
deliveri
system
induc
effect
immun
respons
protect
mice
tumor
cell
percentag
tumorfre
mice
thu
design
dna
construct
would
repres
promis
applic
hpv
vaccin
develop
human
papillomaviru
hpv
common
sexual
transmit
infect
world
main
caus
cervic
cancer
global
cancer
worldwid
case
per
year
men
case
per
year
women
attribut
hpv
viral
type
hpv
identifi
whose
classif
base
associ
cervic
cancer
precursor
lesion
hpv
type
classifi
highrisk
lowrisk
type
consist
gener
squamou
cell
carcinoma
uterin
cervix
papillomaviru
doublestrand
circular
dna
genom
encod
roughli
eight
openread
frame
orf
respons
viral
replic
mainten
cell
transform
gene
product
classifi
six
nonstructur
regulatori
protein
two
structur
capsid
protein
nowaday
viruslik
particl
vlp
base
protein
consid
best
candid
vaccin
develop
hpv
infect
two
commerci
hpv
vaccin
prophylact
gardasil
protect
hpv
genotyp
cervarix
protect
hpv
genotyp
prevent
cervic
cancer
almost
efficaci
hpv
vlp
vaccin
confer
protect
limit
genotyp
although
variabl
level
crossprotect
also
observ
phylogenet
relat
hpv
genotyp
major
impedi
econom
barrier
especi
gap
financ
obstruct
optim
deliveri
vaccin
develop
countri
might
approach
via
local
produc
gener
vaccin
storag
transport
socal
cold
chain
anoth
hindranc
mitig
wwwnaturecomscientificreport
wwwnaturecomscientificreport
lyophil
protect
also
note
mani
recombin
vaccin
reli
multipl
immun
howev
promis
result
could
obtain
singl
dose
certainli
regimen
recent
possibl
approach
broader
crosstyp
protect
immun
lower
cost
consid
vaccin
compar
vlp
immun
inde
current
hpv
vaccin
improv
typespecif
protect
recent
studi
show
region
nterminu
neutral
antibodi
gener
variou
type
hpv
infect
overcom
intrins
low
immunogen
recombin
protein
potenc
could
increas
variou
formul
multival
epitop
peptid
vaccin
fusion
immunogen
protein
multiepitop
dnabas
vaccin
major
field
scienc
bioinformat
brought
togeth
concept
silico
analys
biolog
queri
mathemat
statist
immunoinformat
tool
could
help
research
screen
multipl
hpv
genom
predict
high
immunogen
epitop
provid
b
cell
respons
hpv
infect
studi
combin
silicoin
vivo
approach
use
evalu
protein
highrisk
hpv
type
design
pan
genotyp
construct
develop
dnabas
vaccin
protein
conserv
analysi
select
conserv
epitop
hpv
subtyp
protein
sequenc
align
use
muscl
algorithm
base
degre
conserv
five
region
protein
four
region
protein
select
immunebioinformat
analysi
band
tcell
epitop
predict
among
region
protein
region
protein
highest
score
conserv
highrisk
hpv
type
addit
base
sequenc
variabl
conserv
region
protein
two
main
type
hpv
select
refer
calcul
conserv
iedb
epitop
conserv
analysi
tool
tabl
predict
linear
bcell
epitop
bcell
epitop
recogn
bcell
receptor
antibodi
nativ
structur
continu
bcell
epitop
predict
similar
tcell
epitop
predict
mainli
base
amino
acid
properti
hydrophob
expos
surfac
area
protein
region
sequenc
degre
conserv
type
eatvylppvpvskvv
scientif
report
http
doi
tap
transportproteasom
cleavag
gener
antigen
peptid
transport
across
membran
endoplasm
reticulum
assembl
mhc
class
molecul
essenti
step
antigen
present
cytotox
lymphocyt
thu
investig
proteasom
cleavag
tap
transport
affin
predict
bind
essenti
present
pathway
server
use
predict
tap
transport
effici
proteasom
cleavag
score
tabl
epitop
ylppvpvskvtype
ylpppsvarvtyp
dqfplgrkflltype
dqyplgrkflvtyp
krasatqlyktyp
krasvtdlyktyp
dpdfldivalhrtyp
dsdfmdiirlhrtyp
epitop
highest
epitop
identif
score
scientif
report
http
doi
wwwnaturecomscientificreport
wwwnaturecomscientificreport
charg
secondari
structur
first
step
conserv
region
sequenc
analyz
server
predict
potenti
bcell
epitop
tabl
protein
nfgvppppttslvdtype
epitop
best
b
cell
epitop
identif
score
protein
epitop
show
highest
epitop
identif
score
protein
sequenc
sinc
linear
form
tcell
epitop
bound
mhc
interfac
tcell
ligand
accur
model
studi
use
three
differ
algorithm
publish
motif
ann
quantit
matrix
mhci
two
algorithm
mhcii
ann
quantit
matrix
predict
mhci
first
step
conserv
region
analyz
find
immunodomin
peptid
use
netmhcpan
syfpeithi
propr
protein
peptid
highest
bind
affin
score
determin
highpotenti
ctl
epitop
candid
tabl
analysi
show
ylppvpvskvtype
ylpppsvarvtyp
dqfplgrkflltype
dqyplgrkflvtyp
krasatqlyktyp
krasvtdlyktyp
dpdfldivalhrtyp
dsdfmdiirlhrtyp
epitop
highest
bind
affin
among
protein
sequenc
gener
result
three
differ
algorithm
confirm
conserv
allergen
analys
done
select
epitop
sequenc
epitop
well
conserv
among
highrisk
hpv
type
none
allergen
tabl
addit
crossreact
peptid
human
proteom
studi
use
netmhciipan
propr
server
mhcii
epitop
identif
analysi
tabl
sinc
suitabl
tcell
epitop
predict
bind
differ
hla
allel
epitop
maximum
number
bind
hladr
allel
select
highpotenti
helper
tcell
epitop
candid
among
predict
epitop
eatvylppvpvskvvtyp
tqrlvwacvgvevgrgqtyp
tqrlvwacagveigrgqtyp
dtyrfvtsqaiacqktyp
dtyrfvqsvaitcqktyp
dpsivtliedssvvtsgaptyp
pdfldivalhrpaltsrtyp
sdfmdiirlhrpaltsrtyp
highest
score
bind
affin
also
sequenc
epitop
well
conserv
among
highrisk
hpv
type
none
allergen
tabl
also
crossreact
peptid
human
proteom
popul
coverag
analysi
hla
distribut
vari
among
divers
geograph
region
around
world
thu
design
effect
vaccin
popul
coverag
must
taken
consider
cover
maximum
possibl
popul
studi
popul
coverag
estim
separ
put
epitop
specifi
geograph
region
world
tabl
ctl
epitop
highest
popul
coverag
world
popul
calcul
clear
band
bp
bp
agaros
gel
respect
data
shown
recombin
endotoxinfre
plasmid
ie
concentr
rang
mgml
eukaryot
cell
line
perform
turbofect
transfect
reagent
level
dna
express
evalu
use
fluoresc
microscopi
flow
cytometri
h
posttransfect
data
indic
effect
penetr
cell
vitro
cellular
uptak
gene
cell
respect
deliveri
posit
control
detect
approxim
cell
fig
moreov
spread
green
region
observ
dna
deliveri
use
turbofect
carrier
fluoresc
microscopi
cell
hand
western
blot
analysi
indic
success
express
protein
fuse
gfp
ie
use
antigfp
antibodi
data
indic
clear
band
kda
gfp
respect
use
dab
substrat
fig
evalu
prophylact
effect
design
dna
construct
tumor
growth
surviv
percentag
assess
group
day
challeng
tumor
cell
shown
fig
test
group
immun
dna
construct
demonstr
significantli
lower
tumor
growth
control
group
pb
empti
vector
p
data
show
progress
tumor
growth
control
group
approxim
day
surviv
rate
tumorfre
mice
percentag
interest
group
vaccin
dna
dna
dna
construct
similarli
reduc
tumor
growth
p
shown
fig
group
vaccin
mixtur
dna
construct
show
higher
surviv
rate
dna
construct
alon
antibodi
assay
level
total
immunoglobulin
g
igg
mice
immun
mixtur
dna
construct
significantli
higher
group
p
fig
c
moreov
data
show
level
similar
group
vaccin
dna
construct
p
fig
signific
differ
secret
isotyp
group
receiv
dna
construct
alon
p
fig
signific
anti
antibodi
respons
could
detect
sera
control
group
thu
seroreact
complet
antigenspecif
respons
mice
cytokin
assay
result
cytokin
assay
group
show
level
specif
secret
group
immun
dna
construct
significantli
higher
control
group
p
fig
wwwnaturecomscientificreport
wwwnaturecomscientificreport
fig
furthermor
data
indic
ratio
higher
test
group
compar
control
group
therefor
could
trigger
immun
respons
granzym
b
secret
secret
granzym
b
test
group
significantli
higher
control
group
p
fig
group
immun
dna
construct
produc
significantli
higher
concentr
granzym
b
group
p
level
granzym
b
group
receiv
dna
construct
similar
group
receiv
dna
construct
p
recent
year
develop
bioinformat
tool
appli
vaccin
research
could
potenti
save
time
resourc
inde
immunoinformat
tool
help
identifi
antigen
domain
design
multiepitop
vaccin
sequencebas
technolog
advanc
enough
inform
genom
proteom
differ
virus
thu
use
variou
bioinformat
tool
design
peptid
vaccin
base
neutral
epitop
exampl
silico
design
epitopebas
vaccin
human
immunodefici
viru
coronaviru
dengu
viru
saint
loui
enceph
viru
alreadi
report
around
highrisk
hpv
recogn
current
vaccin
protect
human
type
import
limit
current
vaccin
narrow
coverag
access
fulli
sequenc
proteom
highrisk
hpv
strain
provid
prospect
silico
screen
reliabl
peptidebas
therapeut
vaccin
candid
among
billion
possibl
immunogen
peptid
silico
approach
intend
reflect
possibl
overcom
abovement
difficulti
hpv
multityp
vaccin
gupta
cowork
design
prophylact
multiepitop
dna
vaccin
use
consensu
epitop
sequenc
hpv
capsid
protein
also
evalu
engin
cpg
motif
bioinformat
tool
could
increas
immunogen
dna
vaccin
hosseini
et
al
appli
silico
analysi
protein
hpv
type
identifi
univers
peptid
vaccin
order
protect
mention
type
singh
et
al
analyz
protein
highrisk
hpv
type
identifi
tcell
epitop
suggest
pool
peptid
amino
acid
provid
protect
highrisk
hpv
type
wwwnaturecomscientificreport
wwwnaturecomscientificreport
panahi
colleagu
use
twostep
method
consist
molecular
dock
sequencebas
approach
determin
immunogen
epitop
induct
immun
system
oncoprotein
hpv
type
research
design
framework
comprehens
analysi
conserv
region
highrisk
hpv
type
contain
mhci
mhcii
epitop
framework
begin
conserv
analysi
highrisk
hpv
strain
follow
bcell
epitop
map
tcell
epitop
map
allergen
assess
tap
transport
proteasom
cleavag
popul
coverag
global
templatebas
dock
data
collect
analysi
design
dna
construct
experiment
analysi
final
dna
construct
clone
mammalian
express
vector
green
fluoresc
tag
pegfp
vector
express
evalu
eukaryot
cell
use
flow
cytometri
fluoresc
microscopi
western
blot
moreov
antibodi
tcell
immun
respons
induc
dna
construct
assess
mous
tumor
model
first
sequenc
obtain
highrisk
hpv
type
align
use
muscl
algorithm
conserv
analysi
show
five
region
protein
four
region
protein
conserv
among
subtyp
could
analyz
immunoinformat
input
bcell
epitop
predict
highest
epitop
predict
score
unfortun
reliabl
method
predict
bcell
epitop
reveal
sensit
specif
exist
method
low
specif
sensit
method
respect
case
tcell
epitop
predict
silico
analysi
significantli
improv
thu
result
reliabl
studi
mhci
epitop
epitop
highest
bind
affin
score
addit
abovement
epitop
highest
tcell
epitop
predict
score
obtain
proteasom
cleavag
tap
transport
analysi
high
degre
conserv
observ
subtyp
epitop
epitop
highest
bind
affin
score
among
greatest
degre
conserv
high
similar
highrisk
hpv
type
one
remark
point
epitop
overlap
littl
differ
among
bcell
mhcii
select
epitop
due
limit
mhcpeptid
bind
predict
gap
peptid
predict
bind
mhc
experiment
bind
wwwnaturecomscientificreport
wwwnaturecomscientificreport
employ
address
problem
rais
accuraci
mhcpeptid
predict
current
studi
templatebas
dock
also
global
dock
perform
select
peptid
determin
peptid
would
get
groov
mhc
highest
model
score
mhci
epitop
sequenc
highest
interact
similar
cluster
densiti
score
mhcii
epitop
sequenc
highest
dock
score
studi
mhcipeptid
dock
score
confirm
mhcipeptid
bind
affin
score
epitop
highest
score
method
mhcii
molecular
dock
result
slightli
differ
one
reason
signific
conform
chang
process
due
longer
epitop
length
gener
rule
longer
length
queri
peptid
torsion
conform
flexibl
herein
due
longer
peptid
sequenc
dock
result
mhcii
less
accur
mhci
exampl
averag
similar
score
mhci
variabl
mhcii
complet
analysi
accord
abovement
paramet
two
separ
construct
design
addit
accumul
popul
coverag
helper
tcell
ctl
epitop
design
construct
wwwnaturecomscientificreport
wwwnaturecomscientificreport
estim
construct
combin
epitop
candid
helper
tcell
ctl
singl
univers
vaccin
could
involv
world
popul
rate
respect
fig
previou
studi
ylppvpvskv
krasvtdlyk
report
potenti
immunogen
epitop
abil
vitro
express
design
dna
construct
determin
cell
use
flow
cytometri
western
blot
analysi
transfect
effici
dna
construct
respect
indic
high
potenc
deliveri
eukaryot
cell
known
use
polytop
dna
vaccin
contain
multipl
tcell
bcell
epitop
attract
strategi
develop
therapeut
prophylact
vaccin
hpv
infect
vitro
assay
immunolog
experi
perform
mice
determin
effici
design
dna
construct
without
use
adjuv
deliveri
system
vaccin
develop
similarli
studi
use
pcdna
vector
harbor
gene
interest
immun
without
adjuv
data
indic
group
immun
dna
construct
increas
antibodi
tcell
respons
compar
control
group
furthermor
specif
immun
mice
receiv
mixtur
dna
construct
result
higher
secret
total
igg
cytokin
well
granzym
b
group
higher
level
well
ifngamma
cytokin
group
drive
tcell
respons
toward
immun
studi
show
immunoglobulin
relat
respons
respons
associ
induct
mice
regard
observ
protect
studi
regimen
dna
construct
could
confer
protect
tumorchalleng
mice
surviv
rate
depend
stimul
celldomin
respons
well
granzym
b
secret
indic
ctl
activ
compar
dna
construct
alon
surviv
rate
data
show
high
potenc
combin
dna
construct
versu
dna
construct
alon
prophylact
hpv
vaccin
taken
togeth
immunoinformat
approach
emerg
critic
field
acceler
immunolog
research
yet
immunoinformat
techniqu
appli
tcell
advanc
deal
bcell
moreov
recent
due
limit
option
choos
adjuv
clinic
trial
bioinformat
analys
develop
predict
best
adjuv
way
silico
studi
help
research
save
time
resourc
also
guid
experiment
work
higher
probabl
find
desir
solut
fewer
trial
error
repeat
assay
access
hpv
genom
sequenc
function
character
gene
involv
virul
significantli
improv
understand
molecular
foundat
pathogenesi
hpv
offer
wealth
data
use
design
new
plan
vaccin
design
nowaday
power
immun
system
simul
develop
use
bioinformat
tool
predict
artifici
immun
provid
vaccin
approach
could
predict
best
adjuv
use
human
vaccin
studi
multiscal
comput
infrastructur
approach
stimul
dynam
immun
respons
induc
sever
vaccin
formul
predict
optim
combin
term
adjuv
type
dosag
time
netlogo
agentbas
model
immun
system
run
differ
simul
differ
paramet
set
also
interact
differ
model
strategi
includ
investig
pathogen
growth
life
cycl
model
environ
simul
complex
phenomena
therefor
use
method
increas
effici
reduc
cost
vaccin
studi
studi
first
time
comprehens
integr
method
use
sequencebas
tool
combin
flexibl
peptideprotein
dock
use
design
highli
immunogen
protect
vaccin
candid
abl
boost
humor
cellular
tabl
mhcii
peptid
dock
score
select
helper
tcell
epitop
higher
rate
show
better
qualiti
peptidemhc
interact
wwwnaturecomscientificreport
wwwnaturecomscientificreport
immun
respons
highrisk
hpv
type
addit
vivo
analysi
demonstr
high
potenc
design
construct
combin
dnabas
vaccin
without
use
adjuv
deliveri
system
howev
improv
effici
dnabas
vaccin
use
deliveri
system
also
compar
efficaci
design
peptidebas
vaccin
along
adjuv
near
futur
tabl
physicochem
properti
dna
vaccin
construct
higher
rate
show
high
degre
peptid
antigen
higher
rate
show
high
degre
peptid
solubl
protein
align
conserv
analysi
determin
conserv
epitop
differ
subtyp
sequenc
dataset
first
align
use
snapgen
softwar
gsl
biotech
avail
snapgenecom
protein
align
analysi
use
muscl
algorithm
conserv
epitop
protein
select
immunebioinformat
analysi
band
tcell
epitop
predict
also
calcul
degre
variabl
conserv
epitop
iedb
epitop
conserv
tool
http
toolsimmuneepitopeorgtoolsconserv
use
linear
bcell
epitop
predict
success
vaccin
must
elicit
strong
tcell
bcell
immun
respons
provid
protect
diseas
target
therefor
essenti
show
construct
immunogen
abl
induc
protect
cellular
humor
immun
sinc
antibodi
induc
linear
bcell
epitop
would
difficult
synthes
long
peptid
nativ
protein
conform
resembl
induct
protect
antibodi
howev
optim
peptidebas
vaccin
present
desir
secondari
structur
peptid
order
induc
specif
humor
respons
bcell
epitop
predict
conserv
region
protein
server
http
wwwcb
wwwnaturecomscientificreport
wwwnaturecomscientificreport
employ
studi
epitop
threshold
valu
set
specif
sensit
method
respect
tcell
epitop
predict
mhci
epitop
predict
initi
step
appli
bioinformat
vaccin
research
assess
potenti
immunoprotect
epitop
tcell
epitop
present
mhc
molecul
typic
linear
form
contain
amino
acid
fact
facilit
accur
model
interact
ligand
tcell
thu
select
step
present
antigen
peptid
tcell
receptor
tcr
bind
mhc
molecul
studi
tri
use
three
differ
algorithm
includ
artifici
neural
network
netmhcpan
server
http
wwwcbsdtudkservicesnetmhcpan
quantit
matrix
propr
http
publish
motif
syfpeithi
server
http
wwwsyfpeithid
predict
highpotenti
tcell
epitop
netmhcpan
percentil
rank
set
strong
binder
weak
binder
propr
threshold
set
mhcii
epitop
predict
mhc
class
ii
netmhciipan
server
http
wwwcbsdtudkservic
netmhciipan
propr
http
crddosddnetraghavapropr
employ
predict
potenti
interact
helper
tcell
epitop
peptid
mhcii
case
threshold
strong
weak
binder
set
respect
predict
mhci
peptid
present
pathway
investig
tap
transport
proteasom
cleavag
well
affin
predict
bind
essenti
mhci
present
pathway
studi
use
netctl
server
combin
tap
transportproteasom
cleavag
tool
http
wwwcbsdtudkservicesnetctl
access
predict
antigen
process
mhc
class
antigen
present
pathway
method
paramet
weight
ctermin
cleavag
tap
transport
effici
epitop
identif
set
default
respect
popul
coverag
sinc
respons
tcell
epitop
restrict
mhc
select
epitop
multipl
hlabind
increas
popul
coverag
defin
geograph
region
peptidebas
vaccin
might
employ
coverag
rate
popul
epitop
comput
valid
use
iedb
popul
coverag
tool
populationiedbinput
studi
individu
epitop
bind
hla
allel
analyz
differ
geograph
area
also
select
allergen
crossreact
assess
sinc
protein
import
induc
allergen
reaction
predict
potenti
allergen
import
item
safeti
assess
especi
field
genet
modifi
food
therapeut
biopharmaceut
etc
food
agricultur
organ
fao
world
health
organ
protocol
includ
three
term
evalu
allergen
protein
defin
follow
term
sensit
refer
correctli
predict
allergen
wherea
wwwnaturecomscientificreport
wwwnaturecomscientificreport
specif
refer
correctli
predict
nonallergen
also
accuraci
refer
proport
correctli
predict
protein
allergen
epitop
analyz
pa
p
http
lpasaogabrielunipampa
use
allergen
onlin
wordmatch
afdsmotif
algorithm
base
amino
acid
composit
specif
method
adf
assess
crossreact
peptid
human
proteom
toprank
epitop
analyz
peptid
match
program
http
researchbioinformaticsudeledupeptidematchindexjsp
peptideprotein
flexibl
dock
comput
dock
method
known
import
tool
drug
design
rapid
develop
peptid
therapeut
ration
drug
design
use
new
techniqu
proteinpeptid
dock
inevit
studi
two
differ
algorithm
templatebas
dock
global
dock
perform
galexypepdock
server
http
galaxyseoklaborgcgibin
submitcgi
typepepdock
cab
dock
server
http
biocompchemuweduplcabsdock
estim
format
mhcpeptid
complex
galaxypepdock
server
effect
model
structur
peptideprotein
complex
input
peptid
protein
sequenc
use
structur
databas
energybas
optim
templatebas
dock
cabsdock
server
perform
global
dock
procedur
first
explicit
fulli
flexibl
dock
simul
clusteringbas
score
receptor
flexibl
limit
default
small
backbon
fluctuat
could
increas
includ
select
receptor
fragment
studi
present
exampl
mhcpeptid
dock
perform
individu
epitop
avail
pdb
file
tabl
hla
allel
separ
physicochem
properti
design
construct
base
toprank
epitop
two
differ
construct
design
physicochem
properti
toprank
epitop
solubl
molecular
weight
estim
halftim
instabl
index
antigen
determin
protparam
http
webexpasyorgprotparam
tool
vaxijen
http
wwwddgpharmfacnetvaxijenvaxijenvaxijenhtml
proteinsol
http
proteinsolmanchesteracuk
server
wwwnaturecomscientificreport
wwwnaturecomscientificreport
experiment
studi
construct
recombin
plasmid
bioinformat
analysi
select
peptid
assembl
two
separ
construct
fig
construct
synthes
biomatik
compani
vitro
experi
vector
digest
xhoihindiii
gene
subclon
xhoihindiii
site
vector
individu
ie
recombin
vector
transform
escherichia
coli
e
wwwnaturecomscientificreport
wwwnaturecomscientificreport
coli
strain
extract
plasmid
singl
coloni
use
minikit
qiagen
presenc
insert
fragment
confirm
digest
restrict
enzym
sequenc
vivo
immunolog
assess
vector
digest
bamhihindiii
gene
subclon
bamhihindiii
site
vector
contain
cytomegaloviru
earli
promot
enhanc
sequenc
individu
ie
inde
use
pcdna
vector
harbor
cpg
motif
vivo
studi
final
point
recombin
dna
vector
harbor
gene
purifi
endotoxinfre
plasmid
extra
ef
kit
macherey
nagel
germani
concentr
puriti
recombin
dna
construct
determin
nanodrop
spectrophotometri
vitro
express
dna
construct
cell
human
embryon
kidney
cell
cultur
rpmi
supplement
fetal
bovin
serum
fb
co
atmospher
passag
cell
seed
plate
optim
cell
confluenc
effect
transfect
consid
gener
turbofectplasmid
dna
complex
turbofect
thermo
scientif
plasmid
posit
control
mix
incub
min
room
temperatur
complex
ad
well
serumfre
media
addit
nontransfect
cell
use
neg
control
six
hour
media
replac
complet
rpmi
medium
final
cell
harvest
wash
resuspend
pb
buffer
analyz
express
dna
construct
use
flow
cytometri
fluoresc
microscopi
western
blot
hr
transfect
western
blot
analysi
cell
scrape
plate
wash
wash
step
cell
lyse
wholecel
lysi
buffer
glycerol
nm
dtt
mm
natrium
fluorid
triton
edta
pb
ph
extract
protein
sampl
gfp
separ
sdspage
wv
polyacrylamid
gel
transfer
nitrocellulos
membran
millipor
membran
equilibr
tbst
trisbuff
salin
solut
contain
bsa
bovin
albumin
serum
overnight
antigfp
polyclon
antibodi
vv
acri
antibodi
gmbh
use
recogn
express
protein
standard
procedur
immunoreact
protein
band
visual
detect
peroxidas
activ
use
substrat
name
dab
sigma
peptid
construct
synthesi
immunolog
assay
ie
secret
antibodi
cytokin
granzym
b
two
peptid
construct
peptid
fig
synthes
biomatik
co
puriti
mice
immun
five
group
six
femal
mice
obtain
breed
stock
maintain
pasteur
institut
iran
mhc
haplotyp
immun
day
ie
three
time
interv
plasmid
dna
combin
right
footpad
shown
tabl
control
group
receiv
pb
respect
mice
maintain
specif
pathogenfre
condit
moreov
anim
experiment
procedur
approv
anim
care
use
committe
pasteur
institut
iran
carri
accord
anim
experiment
regul
pasteur
institut
iran
nation
guidelin
scientif
purpos
code
vivo
protect
assay
vaccin
mice
subcutan
challeng
right
flank
tumor
cell
cell
two
week
last
inject
tumor
cell
contain
whole
genom
presenc
gene
confirm
previou
studi
tumor
growth
percentag
tumorfre
mice
monitor
twice
week
palpat
day
postchalleng
time
tumor
volum
calcul
formula
v
b
smallest
diamet
b
biggest
diamet
antibodi
assay
secret
bcell
two
week
last
inject
serum
sampl
collect
group
level
goat
antimous
immunoglobulin
total
igg
antibodi
dilut
bsapbstween
sigma
secret
bcell
measur
pool
sera
group
indirect
elisa
coat
antigen
mixtur
synthet
peptid
moreov
mice
sera
dilut
bsapbstween
cytokin
assay
secret
tcell
three
mice
group
sacrif
spleen
remov
red
blood
celldeplet
pool
splenocyt
cellsml
cultur
plate
h
presenc
peptid
rpmi
neg
control
concanavalin
cona
posit
control
complet
rpmi
cultur
medium
supernat
harvest
assess
secret
tcell
use
sandwichbas
elisa
method
r
system
accord
manufactur
instruct
data
repres
mean
sd
sampl
granzym
b
assay
vitro
ctl
activ
measur
granzym
b
grb
elisa
target
cell
seed
plate
cellswel
incub
mixtur
peptid
h
prepar
splenocyt
effector
cell
e
section
count
ad
target
cell
e
ratio
complet
rpmi
cultur
medium
h
incub
final
supernat
harvest
measur
concentr
grb
elisa
ebiosci
kit
accord
manufactur
instruct
tabl
immun
program
vivo
analysi
